Related Experiment Video

Updated: Aug 15, 2026

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
11:11

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

Natural killer cells: biology and clinical use in cancer therapy

William H D Hallett1, William J Murphy

  • 1Department of Microbiology and Immunology, University of Nevada School of Medicine, University of Nevada, Reno, Reno, NV 89557, USA. wmurphy@unr.edu

Cellular & Molecular Immunology
|October 11, 2005
PubMed

Insights

Natural killer (NK) cells show promise in bone marrow transplants and cancer immunotherapy. Understanding NK cell receptor functions is key to improving clinical outcomes in transplantation and treating hematologic malignancies.

Area of Science:

  • Immunology
  • Hematology
  • Transplantation

Background:

  • Natural killer (NK) cells possess dual roles in bone marrow transplantation (BMT), capable of mediating rejection and promoting engraftment.
  • The clinical application of NK cells for anti-tumor effects and in transplantation remains limited due to incomplete understanding of their biology.
  • NK cell functions are regulated by a balance of activating and inhibitory receptors, which interact with ligands such as major histocompatibility complex (MHC) molecules.

Purpose of the Study:

  • To synthesize current knowledge on NK cell biology, focusing on their role in allogeneic transplantation.
  • To explore the potential of modulating NK cell receptors for enhanced clinical success.
  • To review the application of NK cells as an immunotherapy for cancer and hematologic malignancies.

Main Methods:

  • Review of pre-clinical studies in mice investigating NK cell receptor combinations.
  • Analysis of recent clinical data on KIR-ligand incompatibility in acute myeloid leukemia patients.
  • Synthesis of existing literature on NK cell involvement in BMT and cancer immunotherapy.

Main Results:

  • Pre-clinical models demonstrate that specific NK cell receptor combinations can mitigate graft-versus-host disease (GVHD), improve engraftment, and enhance graft-versus-tumor (GVT) responses.
  • Clinical findings indicate that KIR-ligand incompatibility confers a significant graft-versus-leukemia effect in high-risk acute myeloid leukemia.
  • Modulating NK cell activating and inhibitory receptors is a promising strategy for clinical applications.

Conclusions:

  • A deeper understanding of NK cell receptor dynamics is crucial for unlocking their full clinical potential in BMT and immunotherapy.
  • Targeting NK cell functions offers a viable therapeutic avenue for improving outcomes in leukemia and other hematologic cancers.
  • NK cell-based strategies hold significant promise for advancing cancer treatment and transplantation medicine.

More Related Videos

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...